Analystreport

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $1.75 price target on the stock.

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com